TONIX PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, July 20, 2010, a trademark application was filed for TONIX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the TONIX PHARMACEUTICALS trademark a serial number of 85088881. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, May 1, 2024. This trademark is owned by Krele Pharmaceuticals, Inc.. The TONIX PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development
tonix pharmaceuticals

General Information

Serial Number85088881
Word MarkTONIX PHARMACEUTICALS
Filing DateTuesday, July 20, 2010
Status800 - REGISTERED AND RENEWED
Status DateWednesday, May 1, 2024
Registration Number4656463
Registration DateTuesday, December 16, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2011

Trademark Statements

Pseudo MarkTONICS PHARMACEUTICALS
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 23, 2010
Primary Code042
First Use Anywhere DateFriday, December 30, 2011
First Use In Commerce DateFriday, December 30, 2011

Trademark Owner History

Party NameTONIX PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChatham, NJ 07928
Party NameTONIX PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10022
Party NameKrele Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameKrele Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Saturday, July 24, 2010NOTICE OF PSEUDO MARK MAILED
Friday, July 23, 2010NEW APPLICATION ENTERED
Friday, July 23, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 10, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 2, 2010ASSIGNED TO EXAMINER
Friday, November 12, 2010NON-FINAL ACTION WRITTEN
Friday, November 12, 2010NON-FINAL ACTION E-MAILED
Friday, November 12, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 10, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 10, 2011NON-FINAL ACTION WRITTEN
Friday, June 10, 2011NON-FINAL ACTION E-MAILED
Monday, March 26, 2012SOU TEAS EXTENSION RECEIVED
Friday, June 10, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 10, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 10, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 13, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 30, 2011ASSIGNED TO LIE
Thursday, June 30, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 2, 2011PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 26, 2012SOU EXTENSION 1 FILED
Monday, March 26, 2012SOU EXTENSION 1 GRANTED
Monday, March 25, 2013SOU TEAS EXTENSION RECEIVED
Wednesday, March 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 13, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 20, 2012SOU TEAS EXTENSION RECEIVED
Thursday, September 20, 2012SOU EXTENSION 2 FILED
Friday, September 21, 2012SOU EXTENSION 2 GRANTED
Friday, September 21, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, September 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2013SOU TEAS EXTENSION RECEIVED
Friday, August 30, 2013SOU EXTENSION 4 FILED
Wednesday, September 11, 2013SOU EXTENSION 4 GRANTED
Thursday, September 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 20, 2014SOU EXTENSION 5 FILED
Monday, March 25, 2013SOU EXTENSION 3 FILED
Wednesday, April 17, 2013SOU EXTENSION 3 GRANTED
Monday, April 15, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 20, 2014SOU TEAS EXTENSION RECEIVED
Friday, March 28, 2014SOU EXTENSION 5 GRANTED
Monday, December 16, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, December 16, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, March 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 26, 2014TEAS STATEMENT OF USE RECEIVED
Friday, September 26, 2014USE AMENDMENT FILED
Tuesday, October 7, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, November 7, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 8, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 16, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, February 13, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 9, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 1, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, May 1, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, May 1, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, February 13, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 13, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, December 16, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

pharmaceuticals tonix development pharmaceutical services research medicines preparations drug